A phase III comparison of two toremifene doses to tamoxifen in postmenopausal women with advanced breast cancer

Efficacy and safety of toremifene 60 and 240mg daily (TOR60 and TOR240) are compared to40 mg tamoxifen daily (TAM40) in postmenopausal womenwith advanced estrogen receptor (ER) positive or ERunknown breast cancer. The study is randomized andopen label in three parallel groups. Primary efficacyvariab...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Breast cancer research and treatment 1997-09, Vol.45 (3), p.251-262
Hauptverfasser:	Gershanovich, Michael, Garin, August, Baltina, Dace, Kurvet, Ants, Kangas, Lauri, Ellmén, Juha, Eastern European Study Group
Format:	Artikel
Sprache:	eng
Schlagworte:	Breast cancer Cancer research Medical research
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!